# Trade Mark Journal No.2025/037 12 September 2025

## WO0000001871821 (42,44)

Office of origin: United States of America

Date of International Registration:25 June 2025
Date of designation in the UK: 25 June 2025

Registration of this mark shall give no right to the exclusive use of "IMAGING"

International priority date claimed: 30 December 2024 (United States of America) (98928069)

Class 42
  Scientific research services, namely, integration of imaging results with clinical outcome data utilizing artificial intelligence applications; development of imaging biomarkers for clinical trial purposes; imaging contract research organization services and technology solutions, namely, imaging services for medical and scientific research purposes and technology solutions, namely, reviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting.
Class 44
  Medical radiology, namely, analysis of images from all radiological modalities, such as but not limited to ct, mri and pet scans, to detect and diagnose pre-disease and disease, to evaluate early and longitudinal response to both experimental and standard of care treatments, and to predict and prognose the occurrence or reoccurrence of disease as well as the likelihood of response to treatments; medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals and 3d virtual reconstruction imaging; medical radiology imaging services utilizing medical technologies such as but not limited to disease microenvironment imaging; radiomics, namely, medical radiology services.

Imaging Endpoints II LLC

Representative: Stacie K. Smith Fennemore Craig, P.C., 2394 East Camelback Road, Suite 600, Phoenix AZ 85016-3429, UNITED STATES OF AMERICA